BRADLEY MARK T. (EVP, Chief Integration Officer) received a stock award from KEENOVA THERAPEUTICS PLC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/4/2025ACC: 0001104659-25-073787
Officer· EVP, Chief Integration Officer
Since Jul 2025
+61.90K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
61.90K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+4.29K
Price / share
—
Trade value
—
% of position
New position
7/31/2025
0.00→4.29K
Total
Net shares
+4.29K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 7/31/2025 | A · Award | +4.29K | — | — | New position | 0.00 | 4.29K |
| Total | +4.29K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Ordinary Shares
57.60K shares
Shares
+57.60K
Strike price
Held after
57.60K
Exercisable
—
7/31/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Ordinary Shares57.60K shares | 7/31/2025 | A · Award | +57.60K | — | 57.60K |